Nutix · Pre-Seed
NX
Herbal Wellness · Root-Cause

Nutix

Modern, science-backed ancient herbal wellness

Multi-herb daily formulas built for real efficacy across the recurring concerns people care about most.

Pre-Seed Financing · 2026 01 / 15
Market · The Big Picture 02 / 15

A generational shift to herbal, preventive, root-cause wellness.

$101B → $201B
Global herbal supplements, 2025–2035 at ~7.6% CAGR — already ~21% of all dietary supplements.
Future Market Insights
77% of US adults
Already take supplements (~$60B/yr) — shifting hard toward natural, botanical, condition-specific formats.
CRN / NIH
Root-cause
For chronic, functional, recurring problems, medicine offers side-effect drugs or ‘nothing’s wrong.’ People want another answer.
Industry Reports
Nutix · Pre-Seed Deck 02 / 15
The Problem 03 / 15

Millions cycle through UTIs. Nothing on the shelf actually helps.

Recurrence is the norm
50–60% of women — and a rising share of men — get a UTI; about 1 in 4 recur within a year. It becomes a chronic, life-limiting cycle.
Antibiotics can’t be the answer
They clear an episode but can’t be taken long-term, breed resistance, and do nothing about why it keeps returning.
Supplements underdeliver
Cranberry and D-mannose own the aisle — yet the strongest recent evidence shows little to no benefit for recurrence.
Sources: NIDDK · Cochrane · JAMA Internal Medicine 2024 03 / 15
Voice Of The Customer 04 / 15

People are begging for a solution — in their own words.

I’m stuck in an after-sex UTI cycle. Every. Single. Time.
Antibiotics again. My third round this year. I’m done.
Cranberry and D-mannose did nothing for me.
Honestly? I’m scared to have sex now.

Representative of tens of thousands of posts across r/UTI, r/CautiousBB and TikTok: an organic, high-intent audience no brand has truly served.

Nutix · Pre-Seed Deck 04 / 15
The Evidence 05 / 15

The best-selling ingredient barely beats a placebo.

D-mannose: no benefit

A 2024 JAMA Internal Medicine RCT (598 women, 6 months) found it no better than placebo. Multiple 2025 meta-analyses agree.

Cranberry: weak at best

Modest prevention signal in some groups; little value once symptoms start.

The single-ingredient trap

One molecule against a multi-factor problem. The whole category is built on the wrong model.

% who still got a UTI over 6 months (lower = better)
51%
D-mannose
55.7%
Placebo
Source: Hayward et al., JAMA Internal Medicine 2024;184(6):619–628 (MERIT trial) 05 / 15
Our Thesis 06 / 15

Formula logic, not hero ingredient.

TCM never treats the body with one molecule. It uses multi-herb formulas that work as a system.

2,000 years, now testable
A Cochrane review found Chinese herbal formulas showed real signals for recurrent UTI — we pair that heritage with modern mechanism.
The market agrees
Multi-ingredient formulas already make up ~61% of urology supplements, and herbal extracts are the single largest ingredient type.
Our unfair advantage
Authentic TCM formulation + bilingual cultural fluency is a moat a cranberry brand cannot copy and a strategic cannot build in-house.
Sources: Cochrane CD010446 · Grand View / GMInsights Urology Supplements 2025–26 06 / 15
Market · Our Beachhead 07 / 15

We land where intent is highest: urinary health.

~8.5% CAGR
The urology-supplement market nearly doubles by 2035.
UTI = #1 use
Urinary tract infection is the single largest application segment (~37%).
~61% formula
Multi-ingredient and herbal extracts already lead — our exact model.
DTC fastest
Online is the fastest-growing channel (12–15%), built for a brand like ours.
Global urology-supplement market (USD $B)
$2.4B
2025
$4.9B
2035
Sources: GMInsights · FactMR · Grand View Research 2025–26 07 / 15
The Product 08 / 15

A daily herbal drink people actually want to drink.

Genuinely delicious
A light, refreshing daily drink — not a chalky pill or a bitter tea.
TCM formula, 14 servings
A multi-herb formula in convenient stick packs.
Made in the USA
Premium TCM extracts sourced in China, blended and filled in the US.
Proof on the label
Clinical doses disclosed; third-party COAs and heavy-metals results published.
Nutix · Pre-Seed Deck 08 / 15
Competitive Landscape 09 / 15

Between the single molecule and the everything-blend, there’s us.

BrandModelApproachWho They Serve
AZOCranberry + symptom reliefMass-market, drugstore, symptom-maskingAnyone, in the moment
UqoraD-mannose / cranberry, proactiveDTC, science-branded, single activesRecurrent-UTI women
Cymbiotika / OraBroad herbal wellness, many SKUsPremium, science-styled · no condition depthWellness generalists
NutixTCM condition-specific formulasRoot-cause remedies for recurring imbalancesPeople failed by generic supplements

Against single-ingredient UTI brands we win on formula depth; against broad herbal platforms we win on condition-specific efficacy and real TCM authenticity.

Nutix · Pre-Seed Deck 09 / 15
Who It’s For 10 / 15
Primary Avatar

The active adult

Sexually active men and women, 25–45. Prone to recurring urinary trouble and exhausted by the antibiotic loop.

Buys on trust and results, not hype.

The post-sex urinary moment is universal: we speak to it as everyday vitality.
Nutix · Pre-Seed Deck 10 / 15
How We Make It · Quality & Compliance 11 / 15

Seed-to-sachet: quality proven at every step.

Quality starts with the grower and is verified at every stage — from farm to finished daily powder.

01
Source
USDA GAP/GHP farms. Fair-pay, low-spray. FDA-permitted botanicals.
02
Formulate
In-house R&D. Clinical-level doses. Powder, built to taste.
03
Manufacture
US FDA-reg. facility. cGMP · 21 CFR 111. Identity & potency QC.
04
Test
Independent 3rd-party labs. Heavy metals + microbes. Public COAs.
05
Validate
IRB consumer study. Structure/function only. No disease claims.
06
Improve
Customer feedback loop. Track real outcomes. Iterate the formula.
Compliance backbone — DSHEA structure/function claims · FDA facility registration · FSVP on imported extracts · cGMP quality system · Prop 65 heavy-metal limits · compliant label review
11 / 15
The Platform Vision 12 / 15

One remedy engine. Every recurring concern.

We build only where TCM genuinely beats the alternative, so the platform stays focused — never ‘TCM for everything.’

01

Recurring, chronic or functional — not acute

02

Western medicine underdelivers

03

TCM has a real, formula-level answer

04

Works as a daily drink, in compliant language

Urinary · UTI
Launch SKU
Menstrual
TCM gynecology is its home turf
Menopause
$20B non-hormonal demand surging
Prostate
Opens the male TAM
Digestive
‘Nothing’s wrong’ — TCM’s foundation
Platform TAM → $100B+ global herbal supplements, growing ~8% 12 / 15
Business Model 13 / 15

Subscription-first DTC, then omnichannel.

1 · DTC Subscription
Launch direct. A daily drink is a natural recurring purchase — predictable, high-margin revenue.
2 · Amazon + TikTok Shop
Ride the fastest-growing supplement channels where our audience already searches and shares.
3 · Retail
Whole Foods and premium grocery — unlocked by the ‘Made in USA’ label and category credibility.
Price / Pack~$42Subscription price ~$34
Gross Margin~70%Target at scale
LTV : CAC3:1+Target ratio
CAC Payback<6 moOn subscription
Unit economics are pre-seed targets; margin within premium-supplement 55–65% range 13 / 15
Financial Projections 14 / 15

A credible path to a $13M run-rate by Year 3.

Revenue Gross Profit
$1.2M
$0.74M
$4.8M
$2.98M
$13M
$8.06M
Year 1 Year 2 Year 3
Year 1 — Prove It
One hero SKU, DTC-led, Amazon/TikTok Shop. Nail retention, LTV:CAC and the consumer study.
Year 2 — Scale It
Enter retail later; launch SKU 2 and 3.
Year 3 — Platform
Retail live; 3–4 SKUs across the platform.
Illustrative targets based on stated assumptions; not a guarantee of future performance 14 / 15
Use Of Funds
NX
Raising
$500,000

12–24 months of runway to:

Use Of Funds Breakdown
34% 24% 20% 12%
Growth & marketing34%
Inventory & manufacturing24%
Team20%
Product, R&D & clinical12%
Compliance & legal5%
Ops & G&A5%
01

Launch the hero SKU and reach a $1M+ ARR run-rate

02

Prove retention and LTV:CAC on subscription

03

Complete an IRB consumer perception study

04

Stand up the urologist + TCM advisory board

05

Develop SKU 2 and open the retail conversation

Nutix · Thank You 15 / 15
1 / 15